The Recall Desk
CriticalFDA (Drugs)·D-0342-2018·Announced 2018-02-21

Senna Laxative Tablets Recalled for Containing Naproxen Sodium

Magno Humphries Laboratories is recalling Senna Laxative tablets that were mislabeled and contained Naproxen Sodium instead.

What this means for you

Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.

Our severity reasoning: The recall is classified as FDA Class I, which is the highest severity level indicating a reasonable probability that use of the product will cause serious adverse health consequences or death.

Plain-English summary

Magno Humphries Laboratories, Inc. is recalling 2,400 bottles of Senna Laxative (sennosides) tablets, 8.6 mg, 100-count bottles. The product was manufactured for Basic Drugs, Inc. and distributed nationwide in the USA. The specific lot affected is # 352300 with an expiration date of 01/19.

The recall was initiated due to a labeling error where a customer complaint indicated that a bottle labeled as Senna Laxative contained only tablets of Naproxen Sodium 220 mg. This mix-up poses a risk to consumers who may inadvertently ingest the wrong medication.

Consumers who have purchased this product should check their bottles for the specific lot number and expiration date listed above. If the product matches the description, consumers should stop using it and contact the recalling firm for further instructions.

The recalled product

Product
Senna Laxative (sennosides) tablets, 8.6 mg, 100-count bottles, Manufactured for: Basic Drugs, Inc., Vandalia, Ohio 45377, UPC Code 3 07610 22020 1.
Affected units
2,400

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot # 352300
  • Exp 01/19

Distribution

Distributed nationwide across the United States.

Same manufacturer · Magno Humphries Laboratories, Inc

See all →